Market Tracker

03/30 8:24am ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

394.14
Delayed Data
As of Mar 29
 +11.59 / +3.03%
Today’s Change
325.35
Today|||52-Week Range
452.96
+7.37%
Year-to-Date

Today’s Trading

Previous close382.55
Today’s open382.46
Day’s range382.06 - 401.21
Volume1,945,473
Average volume (3 months)954,591
Market cap$41.8B
Dividend yield--
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+14.93%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+18.44%
P/E ratio51.2
Price/Sales8.79
Price/Book9.39

Competitors

 Today’s
change
Today’s
% change
SHPGShire+0.79+0.45%
INCYIncyte Corp-0.20-0.14%
BAXBaxter International...+0.09+0.17%
ALXNAlexion Pharmaceutic...+2.19+1.85%
Data as of 8:37am ET, 03/30/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts